Evidence map›Paper›PMID 41947424›Full record

ArticleBriefings in bioinformatics2026

Integrated machine learning and molecular dynamics framework for predicting and elucidating ABCB1 allocrite interactions.

Jianjia Su, Yiyang Wu, Wei Xiong, Defang Ouyang

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jianjia SuSchool of Pharmacy, Shenzhen University Medical School, Shenzhen University, No. 1066 Xueyuan Avenue, Nanshan District, Shenzhen, Guangdong, 518055, China.
Yiyang WuState Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, China.
Wei XiongSchool of Pharmacy, Shenzhen University Medical School, Shenzhen University, No. 1066 Xueyuan Avenue, Nanshan District, Shenzhen, Guangdong, 518055, China.
Defang OuyangState Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, China.

Funding

Guangdong Basic and Applied Basic Research Foundation 2021A1515110961Macau Science and Technology Development Fund 0071/2024/RIA1Natural Science Foundation of China 82304411Shenzhen Science and Technology Program 827-00074220Shenzhen Science and Technology Program 860000002111304Shenzhen Science and Technology Program RCBS20221008093120049
6 · The paper itself

Abstract

ABCB1, a polyspecific efflux transporter, mediates multidrug resistance in cancer by interacting with diverse substrates and inhibitors, yet its recognition mechanisms remain elusive. Here, we introduce an integrated framework that synergistically combines biophysics and computational biology to predict ABCB1 allocrite interactions and elucidate their mechanisms. We curated hierarchical-confidence bioactivity datasets from multi-source assays and developed MolMM, a convolutional neural network leveraging meta-learning on noisy data and multi-task learning on refined data, achieving AUC-ROC scores of 83.33% for inhibitors and 81.26% for substrates. SHapley Additive exPlanations (SHAP) analysis revealed key molecular features, highlighting competitive polar, and hydrophobic motifs distinguishing substrates from inhibitors . Building on these ML insights, coarse-grained umbrella sampling simulations mapped these features onto free energy landscapes, proposing an amphiphilic model for substrate binding via a flip-flop process through the transmembrane pore and an inhibitory mechanism stabilizing ABCB1 in transitional conformations at the cavity's gate. This machine learning-molecular dynamics synergy offers mechanistic insights into ABCB1 polyspecificity, facilitating rational design of inhibitors to overcome multidrug resistance.

Indexed as

Machine LearningMolecular Dynamics SimulationATP Binding Cassette Transporter, Subfamily BComputational BiologyHumansProtein BindingABCB1 protein, humanATP Binding Cassette Transporter, Subfamily BABCB1allocrite interactionsmachine learningmolecular dynamicsmultidrug resistance

Identifiers

PMID41947424
PMCPMC13064662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.